Takenaka Toichi | Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
スポンサーリンク
概要
- Takenaka Toichiの詳細を見る
- 同名の論文著者
- Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.の論文著者
関連著者
-
Kawasaki Tomihisa
Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Takenaka Toichi
Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Yui Yoshiki
Third Division Department Of Internal Medicine Faculty Of Medicine Kyoto University
-
Kawai Chuichi
Third Department Of Internal Medicine Kyoto University Faculty Of Medicine
-
Kaku Seiji
Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Katoh Masao
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Yui Yoshiki
Third Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, Kyoto 606-01, Japan
-
Kaku Seiji
Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki 305, Japan
-
Gushima Hiroshi
Research Strategy and Evaluation Division, Yamanouchi Pharmaceutical Co., Ltd.
-
Takenaka Toichi
Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki 305, Japan
-
Katoh Masao
Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki 305, Japan
-
Gushima Hiroshi
Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki 305, Japan
-
GUSHIMA Hiroshi
Research Institute for Food Science, Kyoto University
-
Kawasaki Tomihisa
Cardiovascular and Atherosclerosis Research Laboratories, Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., 21 Miyukigaoka, Tsukuba, Ibaraki 305, Japan
-
Katoh Masao
Molecular Medicine Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Kawamura Susumu
Safety Research Laboratories, Institute for Drug Development Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Katoh Satomi
Safety Research Laboratories, Institute for Drug Development Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Kawai Chuichi
Third Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, Kyoto 606-01, Japan
著作論文
- Thrombolysis with Intracoronary Administration of YM866, a Novel Modified Tissue-Type Plasminogen Activator, in a Canine Model of Coronary Artery Thrombosis.
- Thrombolytic Activity of a Novel Modified Tissue-Type Plasminogen Activator, YM866, in a Canine Model of Coronary Artery Thrombosis.
- Experimental Model of Carotid Artery Thrombosis in Rats and the Thrombolytic Activity of YM866, a Novel Modified Tissue-Type Plasminogen Activator.